Endpoint Clinical and McCreadie Group are collaborating to increase study product accountability transparency for study sponsors, reduce site burdens associated with clinical study investigational medicinal product (IMP) management, and improve related data integrity by integrating McCreadie’s site-based Vestigo application and Endpoint’s PULSE interactive response technology (IRT). Benefits include improved data integrity consistent in format, lowered risk of protocol deviations due to data validation checks, access to site inventory levels, and visibility of intellectual property (IP) disposition, including return and destruction information, resulting in faster data closeout. Site pharmacy teams will gain efficiency by eliminating the need to access multiple systems to document drug receipt, dispensing, and final disposition, and all data entered by site pharmacists will automatically populate via the integration.

McCreadie Group/endpoint Clinical, Inc